Skip to main content

Table 1 Docking studies for compounds (T1-21) with PARP-1 (5DS3)

From: Insilico design, ADMET screening, MM-GBSA binding free energy of novel 1,3,4 oxadiazoles linked Schiff bases as PARP-1 inhibitors targeting breast cancer

Comp

Glide score

Glide EvdW

XP H Bond

Glide emodel

G Rotatable bonds

Glide ecoul

T1

− 3.723

− 30.679

0

− 43.735

1

− 1.373

T2

− 4.355

− 33.583

0

− 47.977

3

− 2.751

T3

− 4.187

− 39.2

0

− 48.686

3

0.462

T4

− 4.112

− 38.044

0

− 53.766

4

− 1.604

T5

− 4.323

− 41.715

0

− 66.406

5

− 3.925

T6

− 4.045

− 38.565

0

− 52.939

5

0.707

T7

− 4.342

− 40.712

0

− 56.312

6

− 0.095

T8

− 5.873

− 44.333

− 0.539

− 66.103

5

− 3.091

T9

− 4.192

− 37.756

0

− 51.971

4

0.225

T10

− 4.674

− 37.194

0

− 51.666

3

− 3.082

T11

− 3.909

− 32.69

0

− 49.102

4

− 2.995

T12

− 5.938

− 34.531

− 0.539

− 55.861

4

− 4.798

T13

− 5.343

− 40.198

− 0.971

− 63.475

4

− 6.149

T14

− 4.585

− 39.039

0

− 53.036

3

0.27

T15

− 3.828

− 33.566

0

− 45.797

4

− 1.594

T16

− 4.291

− 33.122

0

− 46.571

3

0.024

T17

− 4.944

− 38.34

0

− 56.241

3

− 1.871

T18

− 4.004

− 39.049

0

− 53.025

3

1.283

T19

− 4.355

− 36.235

0

− 47.701

3

− 0.252

T20

− 4.556

− 33.874

0

− 50.684

3

− 1.825

T21

− 6.357

− 35.848

− 1.571

− 64.252

5

− 8.412

Olaparib (Std)

− 13.523

− 54.374

− 2.8

− 114.487

6

− 16.488

Tamoxifen (Std)

− 5.045

− 36.865

0

− 56.406

8

− 2.306

  1. Glide score, glide score; Glide EvdW, glide van der Waals energy; XP H Bond, extra precision hydrogen bonding; Glide emodel, glide model energy; G Rotatable bonds, Glide Rotatable bonds; Glide ecoul, glide Coulomb energy